Manufactured by GlaxoSmithKline and Roche Holding AG, Boniva is a popular biposphonate used to treat osteoporosis. Unfortunately, Boniva, like Actonel, has been linked to Osteonecrosis of the Jaw, also known as dead jaw. Osteonecrosis is linked to a loss of blood to the bone tissue, resulting in tissue death and collapse of the bone.
Most Boniva patients realize they have dead jaw after having dental work. Some common symptoms of osteonecrosis of the jaw include:
- Loose teeth
- Jaw and gum pain, infection or swelling
- Exposed bone
- Jaw numbness or loss of sensation
- Dramatic gum loss
While bisphosphonates, including Boniva, have been linked to osteonecrosis of the jaw, the exact nature of the relationship is unknown. Researchers theorize that Boniva can prevent the growth of new blood vessels in the jaw bone tissue. Without new blood vessels, the jawbone tissue cannot heal properly, leading to the degradation of bone mass.
If you have developed dead jaw while taking Boniva, you may be eligible for compensation. Fill out our free case evaluation form on the right to speak with a Boniva lawyer near you.